Correlation Between Cassava Sciences and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cassava Sciences and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cassava Sciences and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cassava Sciences and TG Therapeutics, you can compare the effects of market volatilities on Cassava Sciences and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cassava Sciences with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cassava Sciences and TG Therapeutics.
Diversification Opportunities for Cassava Sciences and TG Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cassava and TGTX is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Cassava Sciences and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Cassava Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cassava Sciences are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Cassava Sciences i.e., Cassava Sciences and TG Therapeutics go up and down completely randomly.
Pair Corralation between Cassava Sciences and TG Therapeutics
Given the investment horizon of 90 days Cassava Sciences is expected to under-perform the TG Therapeutics. In addition to that, Cassava Sciences is 1.28 times more volatile than TG Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest 752.00 in TG Therapeutics on August 30, 2024 and sell it today you would earn a total of 2,748 from holding TG Therapeutics or generate 365.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Cassava Sciences vs. TG Therapeutics
Performance |
| Timeline |
| Cassava Sciences |
| TG Therapeutics |
Cassava Sciences and TG Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cassava Sciences and TG Therapeutics
The main advantage of trading using opposite Cassava Sciences and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cassava Sciences position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.| Cassava Sciences vs. Annovis Bio | Cassava Sciences vs. Axsome Therapeutics | Cassava Sciences vs. Reviva Pharmaceuticals Holdings | Cassava Sciences vs. Seres Therapeutics |
| TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |